Sionna Therapeutics (SION) Operating Expenses (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Operating Expenses data on file, last reported at $29.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 50.56% year-over-year to $29.6 million; the trailing twelve-month figure through Mar 2026 stood at $98.9 million (up 28.36% YoY), and the FY2025 full-year result was $89.0 million, up 26.12% from the prior year.
• Operating Expenses advanced to $29.6 million in Q1 2026, from $23.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $29.6 million in Q1 2026 to a low of $11.3 million in Q2 2024.
• A 3-year average of $21.0 million and a median of $21.9 million in 2025 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 94.0% in 2025, while the deepest fall reached 14.93% in 2025.
• Tracing SION's Operating Expenses over 3 years: stood at $18.1 million in 2024, then jumped by 30.22% to $23.6 million in 2025, then climbed by 25.36% to $29.6 million in 2026.
• Business Quant data shows SION's Operating Expenses at $29.6 million in Q1 2026, $23.6 million in Q4 2025, and $23.8 million in Q3 2025.